GENPHARMASEC Financial Statement Analysis
|
||
|
The Revenues of GENPHARMASEC have increased by 19.16% YoY .
The Earnings Per Share (EPS) of GENPHARMASEC has decreased by -100.00 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
GENPHARMASEC Last 5 Annual Financial Results
[BOM: 531592]
| Consolidated | Mar2024 | Mar2023 |
|---|---|---|
| Revenues | ₹30 Cr | ₹26 Cr |
| Expenses | ₹30 Cr | ₹25 Cr |
| Operating Profit (Excl OI) | ₹0.05 Cr | ₹0.26 Cr |
| Other Income | ₹0.66 Cr | ₹0.10 Cr |
| Interest | ₹0.41 Cr | ₹0.06 Cr |
| Depreciation | ₹0.04 Cr | ₹0.02 Cr |
| Profit Before Tax | ₹0.25 Cr | ₹0.28 Cr |
| Profit After Tax | ₹-0.17 Cr | ₹1.13 Cr |
| Consolidated Net Profit | ₹-0.13 Cr | ₹1.13 Cr |
| Earnings Per Share (Rs) | ₹0.00 | ₹0.04 |
| PAT Margin (%) | -0.56 | 4.41 |
| ROE(%) | -0.42 | 7.34 |
| ROCE(%) | 1.53 | 1.83 |
| Total Debt/Equity(x) | 0.05 | 0.20 |
Key Financials |
||
| Market Cap | : | ₹ 98.0 Cr |
| Revenue (TTM) | : | ₹ 40.6 Cr |
| Net Profit(TTM) | : | ₹ 2.4 Cr |
| EPS (TTM) | : | ₹ 0.0 |
| P/E (TTM) | : | 40.4 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| GENPHARMASEC | -1.1% | -10.2% | -35.7% |
| SUDARSHAN CHEMICAL INDUSTRIES | -4.3% | -17.9% | 21.8% |
| KIRI INDUSTRIES | -0.8% | 0.6% | 48.6% |
| VIDHI SPECIALTY FOOD INGREDIENTS | -7.5% | -9.4% | -26.8% |
| SHREE PUSHKAR CHEMICALS & FERTILISERS | 2.8% | -5.7% | 63.9% |
| BODAL CHEMICALS | -0.2% | -4.7% | -21.1% |
| BHAGERIA INDUSTRIES | 13.3% | 25.9% | 16.4% |
| DYNEMIC PRODUCTS | -2.1% | -6.9% | -25.9% |
| PODDAR PIGMENTS | -2.8% | -4.5% | -34.3% |
GENPHARMASEC Revenues
[BOM: 531592]
| Y-o-Y | 19.16 % |
| 5 Yr CAGR | 19.16 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹30 Cr | 19.16 | |
| Mar2023 | ₹26 Cr | - | |
GENPHARMASEC Operating Profit
[BOM: 531592]
| Y-o-Y | -82.10 % |
| 5 Yr CAGR | -82.10 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹0.05 Cr | -82.10 | |
| Mar2023 | ₹0.26 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -85.15 % |
| 5 Yr CAGR | -85.15 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 0.15% | -85.15 | |
| Mar2023 | 1.01% | - | |
GENPHARMASEC Profit After Tax
[BOM: 531592]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹-0.13 Cr | Negative | |
| Mar2023 | ₹1.13 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | -0.56 % | Negative | |
| Mar2023 | 4.41 % | - | |
GENPHARMASEC Earnings Per Share (EPS)
[BOM: 531592]
| Y-o-Y | -100.00 % |
| 5 Yr CAGR | -100.00 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹0.00 | -100.00 | |
| Mar2023 | ₹0.04 | - | |
GENPHARMASEC Return on Capital Employed (ROCE)
[BOM: 531592]
| Y-o-Y | -16.39 % |
| 5 Yr CAGR | -16.39 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | 1.53% | -16.39 | |
| Mar2023 | 1.83% | - | |
GENPHARMASEC Share Price vs Sensex
| Current Share Price | : | ₹1.8 |
| Current MarketCap | : | ₹ 98.0 Cr |
| Updated EOD on | : | Oct 28,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENPHARMASEC | -1.1% |
-10.2% |
-35.7% |
| SENSEX | 0.3% |
3.6% |
5.5% |
GENPHARMASEC related INDICES
You may also like the below Video Courses
FAQ about GENPHARMASEC Financials
How the annual revenues of GENPHARMASEC have changed ?
The Revenues of GENPHARMASEC have increased by 19.16% YoY .
How the Earnings per Share (EPS) of GENPHARMASEC have changed?
The Earnings Per Share (EPS) of GENPHARMASEC has decreased by -100.00 % YoY .
SUDARSHAN CHEMICAL INDUSTRIES LTD vs KIRI INDUSTRIES LTD vs VIDHI SPECIALTY FOOD INGREDIENTS LTD
SHREE PUSHKAR CHEMICALS & FERTILISERS LTD vs BODAL CHEMICALS LTD vs